METTL3 and hepatocellular carcinoma: The miR-186, which plays the role of anti-hepatoblastoma, is weakly expressed in HCC tissues, and its overexpression inhibits cell aggressive characteristics; however, the increase of its direct target METTL3 reverses the inhibitory effect (Cui et al., 2020).